1: Vandana P, Arnold E. Dasotraline in ADHD: novel or me too drug? Expert Rev Neurother. 2019 Apr;19(4):311-315. doi: 10.1080/14737175.2019.1593826. Epub 2019 Mar 26. PMID: 30871381.
2: Findling RL, Adler LA, Spencer TJ, Goldman R, Hopkins SC, Koblan KS, Kent J, Hsu J, Loebel A. Dasotraline in Children with Attention-Deficit/Hyperactivity Disorder: A Six-Week, Placebo-Controlled, Fixed-Dose Trial. J Child Adolesc Psychopharmacol. 2019 Mar;29(2):80-89. doi: 10.1089/cap.2018.0083. Epub 2019 Jan 29. PMID: 30694697.
3: Yang X, Ryu S, Di L. Dasotraline as a selective cytochrome 2B6 inhibitor for reaction phenotyping. Biopharm Drug Dispos. 2019 Nov;40(9):358-361. doi: 10.1002/bdd.2207. PMID: 31674039.
4: Wigal SB, Hopkins SC, Koblan KS, Childress A, Kent JM, Tsai J, Hsu J, Loebel A, Goldman R. Efficacy and Safety of Dasotraline in Children With ADHD: A Laboratory Classroom Study. J Atten Disord. 2020 Jan;24(2):192-204. doi: 10.1177/1087054719864644. Epub 2019 Aug 2. PMID: 31375051.
5: Grilo CM, McElroy SL, Hudson JI, Tsai J, Navia B, Goldman R, Deng L, Kent J, Loebel A. Efficacy and safety of dasotraline in adults with binge-eating disorder: a randomized, placebo-controlled, fixed-dose clinical trial. CNS Spectr. 2020 May 19:1-10. doi: 10.1017/S1092852920001406. Epub ahead of print. PMID: 32423512.
6: McElroy SL, Hudson JI, Grilo CM, Guerdjikova AI, Deng L, Koblan KS, Goldman R, Navia B, Hopkins S, Loebel A. Efficacy and Safety of Dasotraline in Adults With Binge-Eating Disorder: A Randomized, Placebo-Controlled, Flexible-Dose Clinical Trial. J Clin Psychiatry. 2020 Sep 8;81(5):19m13068. doi: 10.4088/JCP.19m13068. PMID: 32926604.
7: Mosholder AD, Kim J, Davis M, Farchione TR. Re: "Dasotraline in Children with Attention-Deficit/Hyperactivity Disorder: A Six-Week, Placebo-Controlled, Fixed- Dose Trial" by Findling et al. (J Child Adolesc Psychopharmacol 2019;29:80-89). J Child Adolesc Psychopharmacol. 2019 Nov;29(9):725. doi: 10.1089/cap.2019.0061. Epub 2019 May 16. PMID: 31094581.
8: Lew R, Constantinescu CC, Holden D, Carson RE, Carroll V, Galluppi G, Koblan KS, Hopkins SC. The rate of dasotraline brain entry is slow following intravenous administration. Psychopharmacology (Berl). 2020 Nov;237(11):3435-3446. doi: 10.1007/s00213-020-05623-8. Epub 2020 Aug 19. PMID: 32813030; PMCID: PMC7651685.
9: Citrome L. Binge eating disorder revisited: what's new, what's different, what's next. CNS Spectr. 2019 Aug;24(S1):4-13. doi: 10.1017/S1092852919001032. Erratum in: CNS Spectr. 2019 Aug;24(S1):82. PMID: 31196238.
10: Appolinario JC, Nardi AE, McElroy SL. Investigational drugs for the treatment of binge eating disorder (BED): an update. Expert Opin Investig Drugs. 2019 Dec;28(12):1081-1094. doi: 10.1080/13543784.2019.1692813. Epub 2019 Nov 22. PMID: 31714807.